NDC00258-3625-01 — THEOPHYLLINE EXTENDED-RELEASE CA

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00258-3625-01: THEOPHYLLINE EXTENDED-RELEASE CA.

THEOPHYLLINE EXTENDED-RELEASE CA. Key specifications include special_features: ANHYDROUS, features_provided: UNIT DOSE, primary_container_type: STRIP, therapeutic_equivalent: SLO-BID GYROCAP BY RORER PHARM, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_medicament_medicinal_strength: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-164-8737, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00258-3625-01

NSN: 6505-01-164-8737
FSC: 6505 — Drugs and Biologicals
CAGE: 6X308 — INWOOD LABORATORIES INC (USA)

SPECIFICATIONS

special_features	ANHYDROUS
features_provided	UNIT DOSE
primary_container_type	STRIP
therapeutic_equivalent	SLO-BID GYROCAP BY RORER PHARM
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
active_medicament_medicinal_strength	300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
capsule_primary_container_content_quantity	100.000
NSN	6505-01-164-8737

COMPONENT DIAGRAM

KEY FEATURES

•

THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

FEATURES PROVIDED: UNIT DOSE

•

PRIMARY CONTAINER TYPE: STRIP

•

CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT

TECHNICAL CHARACTERISTICS

THERAPEUTIC EQUIVALENT	SLO-BID GYROCAP BY RORER PHARM
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
FEATURES PROVIDED	UNIT DOSE
PRIMARY CONTAINER TYPE	STRIP
SPECIAL FEATURES	ANHYDROUS
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY	100.000
PART NAME ASSIGNED BY CONTROLLING AGENCY	THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
ACTIVE MEDICAMENT MEDICINAL STRENGTH	300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 4

NDC00603-5952-21Reference document

Same NSN cross-reference

Reference document — Secondary reference

NDC00904-7849-60Reference document

Same NSN cross-reference

Reference document — Secondary reference

SLO-BID 300 GYROCAPSReference document

Same NSN cross-reference

Reference document — Secondary reference

SLO-BID 300Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required

Ready to buy NDC00258-3625-01?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00258-3625-01?

NDC00258-3625-01 is a THEOPHYLLINE EXTENDED-RELEASE CA.

What parts can replace NDC00258-3625-01?

There are 4 known substitutes for NDC00258-3625-01: NDC00603-5952-21, NDC00904-7849-60, SLO-BID 300 GYROCAPS and 1 more. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00258-3625-01?

NDC00258-3625-01 is cataloged in the U.S. Government catalog under NSN 6505-01-164-8737. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00258-3625-01 — THEOPHYLLINE EXTENDED-RELEASE CA

Request a Quote — NDC00258-3625-01